7:30 - 8:30 am

Registration and Breakfast

SESSION I: OBESITY AND LIFESTYLE MEDICINE

8:35 - 8:40 am

Chair Introduction and Opening Remarks

Ken Fujioka, MD

8:40 - 9:00 am

Benefits of Bariatric Surgery for the Cardiometabolic Patient

Robert E. Ratner, MD

9:00 - 9:20 am

Obesity Pharmacotherapy: What’s on the Horizon?

Ken Fujioka, MD

9:20 - 9:40 am

Expert Panel Discussion and Q&A

Moderator: Ken Fujioka, MD

Panel: Robert E. Ratner, MD

9:40 – 10:10 am

Keynote

The Special Diabetes Program for Indians: A Current and Future Legacy

Spero M. Manson, PhD

10:15 - 10:45 am

Morning Break and Exhibits

10:50 - 10:55 am

Introduction:

The Great Debate: Which Nutritional Plan is Best for Your Patient?

Ken Fujioka, MD

10:55 - 11:40 am

Part I: Weighing in on the Benefits of Nutritional Plans

Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD

11:40 am - 12:00 pm

Part II: Panel Discussion and Q&A

Moderator: Ken Fujioka, MD

Panel: Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD

12:00 pm

Closing Remarks

Ken Fujioka, MD

12:15 - 1:30 pm

PME Lunch Symposium (NON–CME)

Expert Insights: Managing Cardiovascular Risk Based on the Landmark CV Outcomes Trial (REDUCE-IT™)

Krishnaswami Vijayaraghavan, MD

Sponsored by Amarin Pharma, Inc.

SESSION II: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS

1:45 pm

Chair Introduction

Christie M. Ballantyne, MD

1:45 - 2:05 pm

Updated Lipid Guidelines: What Do They Mean for Clinical Practice?

Salim S. Virani, MD

2:05 - 2:25 pm

Lp(a): When to Measure and How to Treat?

Sotirios Tsimikas, MD

2:25 - 2:45 pm

Navigating the Treatment of Hypertriglyceridemia

Alan Chait, MD

2:45 - 3:15 pm

Challenging Patient Cases and Q&A

Moderator: Christie M. Ballantyne, MD

Panel: Alan Chait, MD; Pamela B. Morris, MD; Sotirios Tsimikas, MD; Salim S. Virani, MD

3:20 - 3:50 pm

Afternoon Break and Exhibits

3:55 - 4:15 pm

New Era of LDL-C Lowering: Evolving Therapies, Evolving Evidence, Evolving Guidance

Pamela B. Morris, MD

4:15 - 4:45 pm

Antithrombotics in Diabetic Patients: Recent Clinical Trial Results

Deepak L. Bhatt, MD, MPH

Supported by an educational grant from AstraZeneca.

4:45 - 5:05 pm

Expert Panel Discussion and Q&A

Moderator: Christie M. Ballantyne, MD

Panel: Deepak L. Bhatt, MD, MPH; Pamela B. Morris, MD

5:05 - 5:10 pm

Closing Remarks

Christie M. Ballantyne, MD

5:15 - 6:15 pm

Reception on the Terrace

6:30 - 7:00 am

Registration

7:10 - 8:25 am

CME Breakfast Symposium

Challenges and Advances in the Diagnosis and Management of Heart Failure with Preserved Ejection Fraction

Chair: JoAnn Lindenfeld, MD

Presenters: Nancy K. Sweitzer, MD; Clyde W. Yancy, MD

Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation.

SESSION III: HEART FAILURE AND HYPERTENSION

8:35 am

Chair Introduction

George L. Bakris, MD

8:35 - 9:10 am

Hypertension: Where We Are and Where We Are Going?

George L. Bakris, MD

9:10 - 9:45 am

End Stage HF: How to Treat and When to Refer?

JoAnn Lindenfeld, MD

9:50 am - 10:20 am

Morning Break and Exhibits

10:20 - 11:00 am

The Story Continues: Heart Failure and Type 2 Diabetes

Matthew R. Weir, MD

Supported by an educational grant from Boehringer Ingelheim and Lilly USA, LLC.

11:00 - 11:35 am

Heart Failure - Should Treatment Vary by Race or Gender?

Clyde W. Yancy, MD

11:35 am - 12:05 pm

Expert Panel Discussion and Q&A

Moderator: George L. Bakris, MD

Panel: Matthew R. Weir, MD; Clyde W. Yancy, MD

12:15 - 1:30 pm

CME Lunch Symposium

Advances in Iron Repletion Therapy: Addressing the Burden of Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Chair: Clyde W. Yancy, MD

Presenters: Andy Y. Lee, MD; Peter A. McCullough, MD

Supported by an educational grant from American Regent.

SESSION IV: DIABETES MANAGEMENT

1:40 - 1:45 pm

Chair Introduction

Jay S. Skyler, MD

1:45 - 2:15 pm

Setting a Target HbA1c: What Do the Guidelines Tell Us?

Athena Philis-Tsimikas, MD

2:15 - 2:45 pm

Initial Combination Therapy versus Sequential Therapy

Ralph A. DeFronzo, MD

2:45 - 3:15 pm

Updates on Cardiovascular Outcomes Trials

Lawrence Blonde, MD

3:20 - 3:50 pm

Afternoon Break and Exhibits

3:55 - 4:25 pm

Insulin: Benefits and Continued Challenges

Irl B. Hirsch, MD

4:25 - 4:55 pm

Impact of Real World Data on the Treatment of Patients with T2DM

Lawrence Blonde, MD

4:55 - 5:10 pm

Expert Panel Discussion and Q&A

Moderator: Jay S. Skyler, MD

Panel: Lawrence Blonde, MD; Ralph A. DeFronzo, MD; Irl B. Hirsch, MD; Athena Philis-Tsimikas, MD

5:10 - 5:15 pm

Meeting Closing Remarks

Jay S. Skyler, MD

CMHC West Women’s Health Summit: Navigating Female Cardiometabolic Care

7:00 - 8:00 am

Registration and Breakfast

8:00 - 8:05 am

Introduction to CMHC Women's Health Summit

Pamela B. Morris, MD

8:05 - 8:30 am

Cardiometabolic Risk in American Indians and Alaska Native Women

Ralph LaForge, MSc

8:30 - 8:55 am

CVD Risk Assessment in Women

Salim S. Virani, MD

8:55 - 9:20 am

Aspirin Therapy for CVD Prevention in Women

Deepak L. Bhatt, MD, MPH

9:20 - 9:45 am

The Intersection Between Breast Cancer and CVD

Bonnie Ky, MD

9:45 - 10:00 am

Mini-break

10:00 - 10:25 am

Cardiometabolic Risk in PCOS and Implications for Management

Andrea Dunaif, MD

10:25 - 10:50 am

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD, FACC

10:50 - 11:15 am

Postmenopausal Hormone Replacement Therapy and CVD: What is the risk?

Cynthia Stuenkel, MD

11:15 - 11:40 am

Diabetes: The Relationship Disease — From a Woman’s Perspective

Anne L. Peters, MD

11:40 - 11:45 am

Conclusions to CMHC Women's Health Summit

Pamela B. Morris, MD